200 essential drugs which, if not available, would threaten the quality of patient care.

The group purchasing organization Vizient has recently identified 200 essential drugs, which include 77 acute and chronic life-savings drugs, and vital chemotherapy drugs which, if not available, would threaten the hospital supply chain and quality of patient care.  Vizient, representing more than half the nation’s acute care providers, said their goal is to increase awareness of supply chain fragility and push manufacturers to increase the available supply of these essential drugs. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.